MAPT and early-onset autosomal dominant Alzheimer disease: Data used is tau PET regional measurements from 198 individuals from the Alzheimer’s Disease Neuroimaging Initiative database, used for discovery, and 42 from the Mayo Clinic Alzheimer’s Disease Research Center and Mayo Clinic Study of Aging (MCSA), used for external validation.